SN/T 1439: Evolution and historical versions
| Std ID | Contents [version] | USD | STEP2 | [PDF] delivered in | Standard Title (Description) | Status |
| SN/T 1439-2025 | English | 459 |
Add to Cart
|
4 days [Need to translate]
|
(Test methods for Ebola virus at frontier ports)
| Valid |
| SN/T 1439-2013 | English | 319 |
Add to Cart
|
3 days [Need to translate]
|
Molecular detection methods of Ebola virus at frontier ports
| Valid |
| SN/T 1439-2004 | English | 639 |
Add to Cart
|
5 days [Need to translate]
|
The frontier port Ebola hemorrhagic fever inspection procedures
| Obsolete |
Standard similar to SN/T 1439-2025
GB 12158 | GBZ 57 | SN/T 5921.2 | SN/T 5921.1 | Basic data
| Standard ID | SN/T 1439-2025 (SN/T1439-2025) |
| Description (Translated English) | (Test methods for Ebola virus at frontier ports) |
| Sector / Industry | Commodity Inspection Standard (Recommended) |
| Date of Issue | 2025-07-25 |
| Date of Implementation | 2026-02-01 |
| Older Standard (superseded by this standard) | SN/T 1439-2013 |
| Issuing agency(ies) | General Administration of Customs |
SN/T 1439-2013: Molecular detection methods of Ebola virus at frontier ports
---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
Molecular detection methods of Ebola virus at frontier ports
People's Republic of China Entry-Exit Inspection and Quarantine Standards
Instead of the SN/T 1439-2004
Ebola virus molecular frontier ports
Biological Detection
Issued on. 2013-03-01
2013-09-16 implementation
People's Republic of China
The State Administration of Quality Supervision, Inspection and Quarantine released
Foreword
This standard was drafted in accordance with GB/T 1.1-2009 given rules.
Instead of the standard SN/T 1439-2004 "frontier port inspection of Ebola hemorrhagic fever virus."
This standard compared with SN/T 1439-2004, the main technical changes are as follows.
--- Modify the standard English name;
--- Original standard detection methods provide, such as virus isolation, electron microscopy, indirect immunofluorescence assay, Western blot test
All related live virus, must be carried out in a BSL-4 laboratory, basically it does not have the maneuverability, therefore, the standard combination
Bio-safety requirements, the original standard, comprehensive method has been modified.
This standard is proposed and managed by the National Certification and Accreditation Administration Committee.
This standard was drafted. People's Republic of China Guangdong Entry Inspection and Quarantine Bureau, People's Republic of China Zhuhai Entry-Exit Inspection and
Quarantine Bureau.
The main drafters of this standard. Huang Ji City, Li Yan, Shi Yong Xia, Cheng Kui, Li Xiaobo, Hong Ye Xing Lu Qin, phase Dapeng, Gobo rotation, Zhong Yuqing,
Mo Qiuhua, Shi Yongmei.
This standard replaces the standards previously issued as follows.
--- SN/T 1439-2004.
Ebola virus molecular frontier ports
Biological Detection
1 Scope
This standard specifies the border crossings suspected cases of Ebola haemorrhagic fever in serum samples required for biosafety Ebola virus detection specimen
Collection, transport and storage, handling specimens 苏丹埃博拉 Zaire Ebola virus and conventional RT-PCR and real-time fluorescence detection
RT-PCR, and detection of Ebola gene chip method.
This standard applies to the border port of entry and exit personnel suspected Ebola haemorrhagic fever cases detected in clinical specimens biological molecules.
2 Normative references
The following documents for the application of this document is essential. For dated references, only the dated version suitable for use herein
Member. For undated references, the latest edition (including any amendments) applies to this document.
GB 19489 General requirements for laboratory biosafety
3 Terms and Definitions
The following terms and definitions apply to this document.
3.1
Ebola hemorrhagic fever Ebolahemorrhagicfever; EHF
By the Ebola virus (Ebolavirus, EBV) causes an acute hemorrhagic diseases. People mainly through contact with infected patients or move
Humoral substance, excretions, secretions and infection, clinical manifestations were fever, bleeding and multiple organ damage. Ebola hemorrhagic fever mortality
High, up to 50% to 90%. The disease in the 1970s, first discovered in Africa, mainly in Africa, Uganda, Congo, Gabon, the Soviet Union
Dan, Ivory Coast, Liberia, South Africa and other endemic countries.
3.2
Ebola Ebolavirus
Also known as Ebola hemorrhagic fever virus, is a filamentous virus family as a single strand of negative-strand RNA virus, which is known to man since the most terrible disease
One drug, the World Health Organization (WHO) as a potential biological warfare agent pathogens. It can be divided into four distinct subtypes. Zaire Ebola
(EBO-Z), 苏丹埃博拉 (EBO-S), Côte d'Ivoire Ebola (EBO-C) and Ebola Reston (EBO-R). The first three subtypes may
Man and primate disease.
4 Abbreviations
The following abbreviations apply to this document.
RT-PCR. reverse transcription - polymerase chain reaction
Real-time fluorescent RT-PCR. Real-time fluorescence reverse transcription - polymerase chain reaction
When the number of cycles of each reaction tube fluorescent signal reaches the threshold set by experienced. Ct values
RNA. ribonucleic acid
FAM. FAM fluorescent dye, a fluorescent reporter group
